Skip to main content
. 2022 Nov 8;13:1033063. doi: 10.3389/fimmu.2022.1033063

Table 2.

Gastrointestinal side effects of patients treated with probiotics (A) or placebo (B) during eradication therapy.

Group A Group B P value
Total 30 (23.62%) 46 (37.70%) 0.016
Vomitting 3 (2.36%) 9 (7.38%) 0.065
Abdominal pain 21 (16.54%) 17 (13.93%) 0.568
Bloating 15 (11.81%) 21 (27.21%) 0.226
Nausea 17 (13.39%) 30 (24.59%) 0.024
Diarrhea 1 (0.79%) 1 (0.82%) 0.977
Belching 8 (6.30%) 12 (9.84%) 0.305
Dysgeusia 4 (3.15%) 4 (3.28%) 0.954